---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026953"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2026-06-03T01:32:29+00:00"
generated_at: "2026-06-03T10:05:24.948876+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $4.7M best-efforts equity offering; 1.45M shares at $3.25 each

## Summary
- Gross proceeds ~$4.7M from sale of 1,449,300 common shares at $3.25/share in a best-efforts offering.
- Placement agent ThinkEquity receives 7.5% cash fee and 5-year warrants for 72,465 shares at $4.0625.
- Net proceeds to be used for working capital, general corporate purposes, and business advancement.
- Offering closed June 2, 2026; shares issued under effective shelf registration statement (Form S-3).

## SEC filing metadata
- accession: 0001493152-26-026953
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2026-06-03T01:32:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315226026953/0001493152-26-026953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315226026953/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026953
- JSON: https://secwatch.observer/filing/0001493152-26-026953.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026953.txt

## Key facts
- Material Agreements
  BriaCell Therapeutics Corp. entered into Placement Agency Agreement with ThinkEquity LLC valued at $4.71 million (effective 2026-05-31).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: ThinkEquity LLC
  - Value: $4.71 million
  - Effective: 2026-05-31
  source text: On May 31, 2026, BriaCell Therapeutics Corp. (the “Company”) entered into a Placement Agency Agreement (the “Agreement”) with ThinkEquity LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610820/000149315226026953/0001493152-26-026953-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.